InsiderSignal.AI

InsiderSignal.ai

ANGO - Angiodynamics Inc

Insider Purchase by Clemmer James C (Pres, CEO)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

4 months ago, Clemmer James C, serving as Pres, CEO at Angiodynamics Inc (ANGO), purchased 10,000 shares at $11.15 per share, for a total transaction value of $111,500.00. Following this transaction, Clemmer James C now holds 882,529 shares of ANGO.

This purchase represents a 1.00% increase in Clemmer James C's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, October 9, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, October 9, 2025, meaning the disclosure happened on the same day as the trade.

Angiodynamics Inc operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Clemmer James C

Pres, CEO

James C. Clemmer is the President, Chief Executive Officer, and Director of AngioDynamics, Inc. (ANGO), a medical device company specializing in innovative, minimally invasive devices for vascular access, surgery, and peripheral vascular disease.[[1]](https://www.zoominfo.com/p/James-Clemmer/59330321)[[2]](https://www.comparably.com/companies/angiodynamics/ceo-rating) He has held these roles since April 2016.[[1]](https://www.zoominfo.com/p/James-Clemmer/59330321)[[2]](https://www.comparably.com/companies/angiodynamics/ceo-rating)[[3]](https://fintool.com/app/research/companies/ANGO/people/james-clemmer) Clemmer brings over 25 years of experience in the medical device industry, starting his career at Sage Products, Inc., which was acquired by Covidien in 1999.[[1]](https://www.zoominfo.com/p/James-Clemmer/59330321)[[2]](https://www.comparably.com/companies/angiodynamics/ceo-rating) He advanced to roles including President of the SharpSafety and Critical Care Divisions (2001-2004), Group President of Kendall Healthcare (a Tyco division, 2004-2006), and President of Covidien's $1.8 billion Medical Supplies segment (2006-2015), overseeing global operations, manufacturing, R&D, and business development across 23 product categories.[[1]](https://www.zoominfo.com/p/James-Clemmer/59330321)[[2]](https://www.comparably.com/companies/angiodynamics/ceo-rating)[[3]](https://fintool.com/app/research/companies/ANGO/people/james-clemmer) A graduate of the Massachusetts College of Liberal Arts (formerly North Adams State College), Clemmer also served as Interim President there (2015-2016) and currently serves as a Trustee; he previously sat on the boards of Lantheus Medical Imaging and AdvaMed.[[1]](https://www.zoominfo.com/p/James-Clemmer/59330321)[[2]](https://www.comparably.com/companies/angiodynamics/ceo-rating)[[3]](https://fintool.com/app/research/companies/ANGO/people/james-clemmer)

View full insider profile →

Trade Price

$11.15

Quantity

10,000

Total Value

$111,500.00

Shares Owned

882,529

Trade Date

Thursday, October 9, 2025

136 days ago

SEC Filing Date

Thursday, October 9, 2025

HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

About Angiodynamics Inc

Company Overview

No company information available
View news mentioning ANGO

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/694720

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime